Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report

• Asıl Yazarlar: Mihriban İnözü (Yazar), Sare Gülfem Özlü (Yazar), Derya Özyörük (Yazar), Saba Kiremitçi (Yazar), Selma Çakmakçı (Yazar), Begüm Avcı (Yazar), Sonay İncesoy Özdemir (Yazar), Umut Selda Bayrakçı (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2022-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Bevacizumab is a monoclonal human antibody that is effective in the treatment of cancers in both adults and children due to inhibition of vascular endothelial growth factor. Throbotic microangiopathy (TMA) is well-known complication of bevacizumab. Herein, we report a case of desmoplastic small roun...